COVID-19 Request Received
Thank you for getting in touch with us regarding your interest in COVID-19 biosamples. Our team will be in touch as soon as possible.
We remain committed to doing everything we can to support ongoing research in this area, and we appreciate your feedback and participation as we work to deliver the critical research materials you need. Thank you for allowing us to be part of the work you do!
Your source for all things biotech
Stay informed with our expert insights, industry news, and groundbreaking discoveries.
New Research Shows Promise for Detecting Deadly Cancers via Blood Test
TIME reports that scientists are making inroads when it comes to creating ways to detect many types of cancer at...
Embryos have full human regeneration and regeneration could be key for radical life extension
Nextbigfuture interviewed Michael West, CEO of the startup AgeX for nearly three hours today. The key to human regeneration is...
Opinion: Patients on biologics need to be wary of substitutions
On a cool rainy day last month, more than 100 people rallied at the British Columbia legislature to fight for...
Chinese firm clones gene-edited dog for blood disorder research
Disease is leading cause of stroke, heart disease.BEIJING (CNN) - With his black, brown and white fur, Longlong looks like...
Physicians, patients should be aware of the potential benefits, risks associated with biologic treatments for osteoarthritis
Biologics may lack the efficacy and safety of traditional orthopaedic treatments. ROSEMONT, Ill., Dec. 20, 2017 /PRNewswire-USNewswire/ -- The American...
